Camrelizumab [1798286-48-2]

TargetMol Chemicals

Camrelizumab

10

1798286-48-2

Antibody

Research Use Only

Camrelizumab

98.60%

143.7 kDa

Camrelizumab (SHR-1210) is a human IgG4-kappa monoclonal antibody with high affinity directed against PD-1, binding PD-1 with an affinity of up to 3 nM and inhibiting PD-1/PD-L1 with an IC50 of 0.70 nM. Camrelizumab exhibits anti-tumor activity and is well tolerated in cancers, including NSC-LC, ESCC, Hodgkins lymphoma, and advanced HCC.

3 years

-20°C

12352203